Dariusz Boroń

816 total citations
75 papers, 530 citations indexed

About

Dariusz Boroń is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dariusz Boroń has authored 75 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Dariusz Boroń's work include MicroRNA in disease regulation (16 papers), Angiogenesis and VEGF in Cancer (10 papers) and Cancer-related molecular mechanisms research (8 papers). Dariusz Boroń is often cited by papers focused on MicroRNA in disease regulation (16 papers), Angiogenesis and VEGF in Cancer (10 papers) and Cancer-related molecular mechanisms research (8 papers). Dariusz Boroń collaborates with scholars based in Poland, United States and Slovakia. Dariusz Boroń's co-authors include Beniamin Oskar Grabarek, Nikola Zmarzły, Marcin Opławski, Daniel Kotrych, Anna Bogacz, Ryszard Brus, Joanna Rosińćzuk, Bogusław Czerny, Marek Michalski and Agnieszka Seremak‐Mrozikiewicz and has published in prestigious journals such as Scientific Reports, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Dariusz Boroń

71 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dariusz Boroń Poland 14 234 148 91 81 75 75 530
Kun Shi China 16 289 1.2× 106 0.7× 81 0.9× 176 2.2× 36 0.5× 35 713
Ilma Simoni Brum Brazil 20 319 1.4× 118 0.8× 109 1.2× 101 1.2× 103 1.4× 67 843
G. Bonatz Germany 13 216 0.9× 75 0.5× 113 1.2× 85 1.0× 58 0.8× 21 624
Zhenling Wang China 16 298 1.3× 120 0.8× 110 1.2× 85 1.0× 16 0.2× 33 705
Yubo Zhao China 11 196 0.8× 111 0.8× 37 0.4× 32 0.4× 46 0.6× 29 407
Mohammad‐Taher Moradi Iran 14 216 0.9× 147 1.0× 101 1.1× 69 0.9× 24 0.3× 47 496
Claudia A. Krusche Germany 17 353 1.5× 44 0.3× 101 1.1× 216 2.7× 111 1.5× 35 973

Countries citing papers authored by Dariusz Boroń

Since Specialization
Citations

This map shows the geographic impact of Dariusz Boroń's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dariusz Boroń with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dariusz Boroń more than expected).

Fields of papers citing papers by Dariusz Boroń

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dariusz Boroń. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dariusz Boroń. The network helps show where Dariusz Boroń may publish in the future.

Co-authorship network of co-authors of Dariusz Boroń

This figure shows the co-authorship network connecting the top 25 collaborators of Dariusz Boroń. A scholar is included among the top collaborators of Dariusz Boroń based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dariusz Boroń. Dariusz Boroń is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zmarzły, Nikola, et al.. (2024). miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer. International Journal of Molecular Sciences. 25(18). 10088–10088. 2 indexed citations
2.
Opławski, Marcin, et al.. (2024). Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast Cancer. International Journal of Molecular Sciences. 25(12). 6546–6546. 4 indexed citations
3.
4.
Zmarzły, Nikola, et al.. (2022). miRNAs Participate in the Regulation of Oxidative Stress-Related Gene Expression in Endometrioid Endometrial Cancer. International Journal of Molecular Sciences. 23(24). 15817–15817. 6 indexed citations
5.
Boroń, Dariusz, et al.. (2021). Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer. Journal of Clinical Medicine. 10(13). 2787–2787. 22 indexed citations
6.
Opławski, Marcin, et al.. (2021). Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer. Journal of Clinical Medicine. 10(7). 1520–1520. 14 indexed citations
7.
Zmarzły, Nikola, et al.. (2021). Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer. Journal of Clinical Medicine. 10(21). 4872–4872. 6 indexed citations
8.
Grabarek, Beniamin Oskar, et al.. (2021). Microbiological effects in patients with leg ulcers and diabetic foot treated with Lucilia sericata larvae. International Wound Journal. 19(1). 135–143. 15 indexed citations
9.
Opławski, Marcin, et al.. (2021). Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. Biomedicines. 9(11). 1535–1535. 4 indexed citations
10.
11.
Grabarek, Beniamin Oskar, et al.. (2020). Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line. Current Pharmaceutical Biotechnology. 21(12). 1269–1277. 4 indexed citations
12.
13.
Grabarek, Beniamin Oskar, et al.. (2020). Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer in vitro under Cisplatin Treatment. Current Pharmaceutical Biotechnology. 21(11). 1119–1128. 3 indexed citations
14.
Grabarek, Beniamin Oskar, et al.. (2020). Cisplatin Changes Expression of SEMA3B in Endometrial Cancer. Current Pharmaceutical Biotechnology. 21(13). 1368–1376. 4 indexed citations
15.
Zmarzły, Nikola, et al.. (2020). Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer. Current Pharmaceutical Biotechnology. 22(12). 1663–1671. 13 indexed citations
16.
Opławski, Marcin, et al.. (2019). Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level. Current Pharmaceutical Biotechnology. 21(7). 635–641. 3 indexed citations
17.
Opławski, Marcin, et al.. (2019). Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer. Current Pharmaceutical Biotechnology. 21(1). 45–51. 6 indexed citations
18.
Opławski, Marcin, et al.. (2019). Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer. Current Pharmaceutical Biotechnology. 20(12). 1004–1010. 15 indexed citations
19.
Opławski, Marcin, et al.. (2019). Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer. Current Pharmaceutical Biotechnology. 21(1). 52–59. 12 indexed citations
20.
Boroń, Dariusz, et al.. (2015). Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women. International Immunopharmacology. 28(1). 477–486. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kun Shi Breakdown of academic impact, for papers by Ilma Simoni Brum Breakdown of academic impact, for papers by G. Bonatz Breakdown of academic impact, for papers by Zhenling Wang Breakdown of academic impact, for papers by Yubo Zhao Breakdown of academic impact, for papers by Mohammad‐Taher Moradi Breakdown of academic impact, for papers by Claudia A. Krusche
Rankless by CCL
2026